NSRGF NESTLE SA
- 104.500
- -1.020-0.97%
NESTLE SA News
Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
On Tuesday, Nestlé SA (OTC:NSRGF) (OTC:NSRGY) unveiled Vital Pursuit, a new line of foods designed to complement GLP-1 weight loss medications and aid consumers focused on weight management. This com
Nestle Set to Sell $5 Pizza, Sandwiches for Wegovy, Ozempic Users
Nestle's Nescafe to Invest $196 Million in Brazil by 2026 to Tap Surging Demand
Nestle SA's Dividend Analysis
NESTLE SA To Go Ex-Dividend On April 22nd, 2024 With 3.0828 USD Dividend Per Share
April 19th - $NESTLE SA(NSRGF.US)$ is trading ex-dividend on April 22nd, 2024. Shareholders of record on April 23rd, 2024 will receive 3.0828 USD dividend per share on April 24th, 2024. The ex-div
Shareholders Reject Proposal to Cut Nestle's Reliance on Unhealthy Products
Nestlé (VTX:NESN) Shareholders Have Endured a 14% Loss From Investing in the Stock a Year Ago
Domino's Pledges to Cut Calories of Its Food After Creme Egg Cookie Backlash
15 Biggest Swiss Companies
A Better Return Than Nvidia or Bitcoin? It's Dark and Delicious
Magnificent 7 Stocks Become The Star Attractions For Norway's Sovereign Wealth Fund
If anyone needs any proof of how the landscape of investment has changed as a result of a handful of technology companies over the past decade, take a look at the world's biggest sovereign wealth fund
MHGVY Vs. NSRGY: Which Stock Should Value Investors Buy Now?
More Than 440,000 Starbucks-branded Mugs Recalled Due to Burn, Laceration Risk
Nestlé (VTX:NESN) Has Announced That It Will Be Increasing Its Dividend To CHF3.00
Rebel Investors Want KitKat Maker Nestle to Cut Back on Junk Food—but the Fortunes of Its Mindful Chef Brand Suggest Customers Aren't Ready for a Health Kick
Britain's Biggest Investor Tells Nestlé to Sell Less Chocolate
Shareholder Activists Call on Nestle to Tackle Reliance on Unhealthy Food Sales
15 Best Alternatives to Starbucks Coffee
UPDATE 1-Skin Care Company Announces Price Range for $2.6 Billion Flotation
Q4 2023 Seres Therapeutics Inc Earnings Call
Analysis
Price Target
No Data
